MedPath

Comparison of Magnesium sulphate adjuvant Perineurally vs intravenously to levobupivacaine in usg guided supraclavicular block

Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2022/12/048238
Lead Sponsor
Chettinad Academy of Research and Education
Brief Summary

To compare analgesic efficacy between perineural and intravenous magnesium sulphate as an adjuvant to levobupivacaine in ultrasound-guided supraclavicular brachial plexus block



Group 1 perineural magnesium sulphate – patient will receive 0.5% levobupivacaine (24.5ml) with 250 mg of magnesium sulphate (0.5ml) total volume of 25ml in usg guided supraclavicular nerve block

Group 2 intravenous magnesium sulphate – patient will receive 0.5% levobupivacaine  (24.5ml) with 0.5ml NS total volume of 25ml in usg guided supraclavicular nerve block plus 30 mg/kg iv magnesium sulphate



Primary objective

•To compare the duration of analgesia

Secondary objective

•To compare the onset of sensory and motor block

•To compare the requirement of rescue analgesic in the postoperative period

•To compare the side effects (if any)

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
52
Inclusion Criteria
    1. Age between 18.
  • 60 years 2.Both sexes3. ASA Classes I,II and III patients 4. Patients posted for upper limb surgery below shoulder.
Exclusion Criteria
  • 1.Patient refusal2.
  • Coagulopathy3.
  • History of allergy to local anesthetics4.
  • Infection at the site of block5.
  • Neurodeficit involving brachial plexus6.
  • Pregnant women7.
  • Patients with psychiatric behavior8.
  • ASA Class IV patients 9.Obese patients BMI>35kg/m2.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the duration of analgesia2 years
Secondary Outcome Measures
NameTimeMethod
• To compare the onset of sensory and motor block•To compare the requirement of rescue analgesic in the postoperative period

Trial Locations

Locations (1)

Chettinad Hospital and Research Institute

🇮🇳

Chennai, TAMIL NADU, India

Chettinad Hospital and Research Institute
🇮🇳Chennai, TAMIL NADU, India
Dr Koushallya Sri S
Principal investigator
7299224444
akskoush@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.